NAD+
NAD+ appears in 3,067 indexed publications going back to 2017, including 337 in the past twelve months. 204 registered trials appear on ClinicalTrials.gov, 2 with Australian sites.
On This Figure
NAD+ is a coenzyme present in every living cell, so this figure describes an entire field of metabolic research rather than one compound.
Publication history
How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 0 |
|---|---|
| 2016 | 0 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 18 |
| 2020 | 34 |
| 2021 | 59 |
| 2022 | 109 |
| 2023 | 130 |
| 2024 | 199 |
| 2025 | 232 |
| 2026 | 210 |
Who is looking it up
Monthly readers of the NAD+ article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.
The registered pipeline
2 trials have a registered Australian site.
Phase distribution across the most recently updated registered trials.
- Not yet recruiting·Not applicable
NAD Supplementation in Parkinson's Disease
University of Oklahoma · estimated completion 2027-06
- Not yet recruiting·Phase 3
Edaravone Dexborneol for Post-Stroke Epilepsy
First Affiliated Hospital of Wenzhou Medical University · estimated completion 2030-06
- Recruiting·Phase 2
NAD Augmentation in Diabetes Kidney Disease
Brigham and Women's Hospital · estimated completion 2026-11-30
- Completed·Phase 1
NAD Supplementation and Vascular Health in PAD
University of Oklahoma · completed 2024-07-30
- Recruiting·Phase 1
Brigham and Women's Hospital · estimated completion 2027-12-31
- Withdrawn·Phase 1
Oxaloacetate in Myasthenia Gravis
University of Kansas Medical Center · completed 2026-08
Most recent work
The newest indexed records mentioning NAD+, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.
- 2026-06-27·Bioactive materials
Jiang J, Chen J, Wang X et al.
- 2026-02-12·Pharmaceutical science advances
Shi L, Huang X, Han X et al.
- 2026-04-16·Renal failure
Zhang Y, Wang Y, Qiao Y et al.
- 2026-03-10·Gut microbes
Huang J, Qin Q, Li X et al.
- 2026-04-27·Biomaterials
Huang B, Xu W, Qiu X et al.
- 2026-06-24·Experimental neurology
Programmed axon degeneration gene variants in human disease
Hopkins EL, Williams PA. et al.
- 2025-10-18·Genes & diseases
Wang J, Wang J, Xie W et al.
- 2026-05-05·Theriogenology
Luo J, Wang S, Lin X et al.
NAD+ available from Polaris Research
Supplied as research materials for laboratory use. Free express delivery Australia wide.
Sources
Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.